Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously

Mariana Tudoran1,2,3, Cristina Tudoran1,2, Voichita Elena Lazureanu4

  • 1Department VII, Internal Medicine II, Discipline of Cardiology, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.

Insights

Post-COVID-19 patients often experience persistent cardiac issues, including left ventricular systolic function alterations and diastolic dysfunction. Elevated myocardial necrosis markers during acute infection may predict future cardiac performance decline.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Echocardiography

Background:

  • Coronavirus disease (COVID-19) is a severe respiratory illness with known cardiovascular complications.
  • This study investigates persistent cardiac dysfunction in COVID-19 survivors without prior cardiovascular disease.

Purpose of the Study:

  • To assess left ventricular systolic function (LV-SF) and diastolic dysfunction (DD) in COVID-19 patients post-recovery.
  • To identify predictors of cardiac dysfunction following moderate COVID-19 pneumonia.

Main Methods:

  • 125 patients hospitalized for moderate COVID-19 pneumonia underwent transthoracic echocardiography (TTE) 6-10 weeks after discharge.
  • Analysis included in-hospital laboratory data (CK-MB) and thorax CT scans.
  • Multivariate regression identified factors associated with LV-SF decrease.

Main Results:

  • Transthoracic echocardiography revealed LV-SF alterations in 8.8% and diastolic dysfunction in 16.8% of patients.
  • Cardiac dysfunction correlated with initial levels of creatine kinase-MB (CK-MB) and inflammatory markers.
  • CK-MB levels, age, and BMI accounted for 65% of the decrease in LV-SF.

Conclusions:

  • Left ventricular systolic and diastolic dysfunction are common sequelae of COVID-19 infection.
  • These cardiac alterations may contribute to persistent symptoms in post-acute COVID-19.
  • Elevated myocardial necrosis markers during acute COVID-19 infection predict subsequent cardiac performance impairment.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
124
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
129
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
106
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
159
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
76